{'fraction_non_alphanumeric': 0.037953795379537955, 'fraction_numerical': 0.009075907590759076, 'mean_word_length': 5.157360406091371, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
SPECTROPHOTOMETRIC AND THERMAL STUDIES OF CHARGE TRANSFER COMPLEXES

Itraconazole (ITZ) is a distinguished antifungal representative that also has anticancer commotion. In this study, we recognize ITZ as a w i d e ranging inhibitor of enteroviruses (e.g.,poliovirus, coxsackievirus, enterovirus-71, rhinovirus). We exhibit that ITZ reduces viral RNA d u p l i c a t i o n by aiming oxysterol-binding protein (OSBP) and OSBP-related protein 4(ORP4). Time after time, OSW-1, a precise OSBP/ORP4 antagonist, too restrains enterovirus replication. Giveaway of OSBP inhibits virus replication, while over expression of OSBP or ORP4 offsets the antiviral belongings of ITZ and OSW-1. ITZ binds OSBP and inhibits its purpose, i.e., shuttling of cholesterol and phosphatidylinositol-4-phosphate between membranes, thus likely disturbing the virus-induced membrane alterations are also indispensable for viral replication organelle construction. ITZ also inhibits hepatitis C virus replication, which also relies on OSBP. Together, these data implicate OSBP/ORP4 as molecular targets of ITZ and point to an imperative utility of OSBP/ORP4-mediated lipid barter in virus replication that can be besieged by antiviral meds.